A 10-year retrospective review of exposures to volatile nitrites reported to the Victorian Poisons Information Centre.

IF 3 3区 医学 Q2 TOXICOLOGY Clinical Toxicology Pub Date : 2024-11-11 DOI:10.1080/15563650.2024.2423832
James White, Rohan A Elliott
{"title":"A 10-year retrospective review of exposures to volatile nitrites reported to the Victorian Poisons Information Centre.","authors":"James White, Rohan A Elliott","doi":"10.1080/15563650.2024.2423832","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Volatile nitrites, such as amyl nitrite, are used recreationally to enhance sexual experience and provide a feeling of euphoria. They are associated with severe adverse reactions including methaemoglobinaemia and maculopathy. The aim of this study was to explore the epidemiology and clinical effects of volatile nitrite exposures reported to the Victorian Poisons Information Centre in Australia over a 10-year period.</p><p><strong>Methods: </strong>This was a retrospective, observational study of poison centre call records. Data were extracted for all exposures to volatile nitrites reported from 2013 to 2022.</p><p><strong>Results: </strong>There were 132 calls about volatile nitrites, representing 122 exposures, with a more than five-fold increase in the annual number of exposures (from five in 2013 to 26 in 2022). Ingestion (49.2%) and inhalation (27.9%) were the most common routes of exposure. Seventy-six (62.3%) patients reported one or more symptoms related to volatile nitrite exposure. The most common symptoms were light-headedness/dizziness (20.5%), oro-mucosal irritation (15.6%), ocular irritation (14.8%), nasal irritation (12.3%), and nausea/vomiting (9.8%). Less common, but potentially serious, adverse effects included methaemoglobinaemia (4.1%), hypoxia (1.6%) and hypotension (0.8%). Symptom severity was usually classified as minor (70/76, 92.1%) at the time of the poisons centre call. Fifty-four (44.3%) patients were either in the hospital when the poisons centre was contacted or were referred to the hospital by the poisons centre.</p><p><strong>Discussion: </strong>The increase in reported volatile nitrite exposures observed in this study aligns with epidemiological data showing an increase in volatile nitrite usage in Australia. The findings about the nature of exposures and symptoms experienced can be used to inform harm reduction and education efforts for community members and health professionals.</p><p><strong>Conclusions: </strong>Exposures to volatile nitrites reported to an Australian poisons centre increased between 2013 and 2022. More than 40% of exposures resulted in a hospital presentation. Methaemoglobinaemia was reported in 4.1% of cases.</p>","PeriodicalId":10430,"journal":{"name":"Clinical Toxicology","volume":" ","pages":"1-5"},"PeriodicalIF":3.0000,"publicationDate":"2024-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Toxicology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/15563650.2024.2423832","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"TOXICOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Volatile nitrites, such as amyl nitrite, are used recreationally to enhance sexual experience and provide a feeling of euphoria. They are associated with severe adverse reactions including methaemoglobinaemia and maculopathy. The aim of this study was to explore the epidemiology and clinical effects of volatile nitrite exposures reported to the Victorian Poisons Information Centre in Australia over a 10-year period.

Methods: This was a retrospective, observational study of poison centre call records. Data were extracted for all exposures to volatile nitrites reported from 2013 to 2022.

Results: There were 132 calls about volatile nitrites, representing 122 exposures, with a more than five-fold increase in the annual number of exposures (from five in 2013 to 26 in 2022). Ingestion (49.2%) and inhalation (27.9%) were the most common routes of exposure. Seventy-six (62.3%) patients reported one or more symptoms related to volatile nitrite exposure. The most common symptoms were light-headedness/dizziness (20.5%), oro-mucosal irritation (15.6%), ocular irritation (14.8%), nasal irritation (12.3%), and nausea/vomiting (9.8%). Less common, but potentially serious, adverse effects included methaemoglobinaemia (4.1%), hypoxia (1.6%) and hypotension (0.8%). Symptom severity was usually classified as minor (70/76, 92.1%) at the time of the poisons centre call. Fifty-four (44.3%) patients were either in the hospital when the poisons centre was contacted or were referred to the hospital by the poisons centre.

Discussion: The increase in reported volatile nitrite exposures observed in this study aligns with epidemiological data showing an increase in volatile nitrite usage in Australia. The findings about the nature of exposures and symptoms experienced can be used to inform harm reduction and education efforts for community members and health professionals.

Conclusions: Exposures to volatile nitrites reported to an Australian poisons centre increased between 2013 and 2022. More than 40% of exposures resulted in a hospital presentation. Methaemoglobinaemia was reported in 4.1% of cases.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
对维多利亚州毒药信息中心报告的接触挥发性亚硝酸盐的情况进行了为期 10 年的回顾性审查。
简介:亚硝酸戊酯等挥发性亚硝酸盐被用于娱乐,以增强性体验并提供兴奋感。它们与严重的不良反应有关,包括高铁血红蛋白血症和黄斑病变。本研究旨在探讨澳大利亚维多利亚州毒药信息中心在 10 年间报告的亚硝酸挥发物暴露的流行病学和临床影响:这是一项对毒物中心呼叫记录进行的回顾性观察研究。提取了 2013 年至 2022 年期间报告的所有接触挥发性亚硝酸盐的数据:结果:共接到 132 个有关挥发性亚硝酸盐的电话,代表 122 次暴露,每年的暴露次数增加了 5 倍多(从 2013 年的 5 次增加到 2022 年的 26 次)。摄入(49.2%)和吸入(27.9%)是最常见的接触途径。76名患者(62.3%)报告了一种或多种与接触挥发性亚硝酸盐有关的症状。最常见的症状是头昏/头晕(20.5%)、口腔粘膜刺激(15.6%)、眼部刺激(14.8%)、鼻部刺激(12.3%)和恶心/呕吐(9.8%)。不太常见但可能很严重的不良反应包括高铁血红蛋白血症(4.1%)、缺氧(1.6%)和低血压(0.8%)。在毒物中心呼叫时,症状严重程度通常被归类为轻微(70/76,92.1%)。有 54 名患者(44.3%)在联系毒物中心时已在医院,或由毒物中心转诊至医院:讨论:本研究中观察到的挥发性亚硝酸盐暴露报告的增加与流行病学数据显示的澳大利亚挥发性亚硝酸盐使用量的增加相一致。有关接触亚硝酸盐的性质和症状的研究结果可用于为社区成员和卫生专业人员提供减低危害和教育的信息:结论:2013 年至 2022 年期间,澳大利亚毒物中心收到的挥发性亚硝酸盐接触报告有所增加。40%以上的暴露导致了住院治疗。4.1%的病例报告了高铁血红蛋白血症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Clinical Toxicology
Clinical Toxicology 医学-毒理学
CiteScore
5.70
自引率
12.10%
发文量
148
审稿时长
4-8 weeks
期刊介绍: clinical Toxicology publishes peer-reviewed scientific research and clinical advances in clinical toxicology. The journal reflects the professional concerns and best scientific judgment of its sponsors, the American Academy of Clinical Toxicology, the European Association of Poisons Centres and Clinical Toxicologists, the American Association of Poison Control Centers and the Asia Pacific Association of Medical Toxicology and, as such, is the leading international journal in the specialty.
期刊最新文献
Ethanol for the management of alcohol withdrawal syndrome: a systematic review. A 10-year retrospective review of exposures to volatile nitrites reported to the Victorian Poisons Information Centre. Response to West et al. "Identifying and quantifying exposures involving counterfeit opioid analgesic products". Augmenting the sensitivity for hepatotoxicity prediction in acute paracetamol overdose: combining psi (ψ) parameter and paracetamol concentration aminotransferase activity multiplication product. Reported recreational drug and new psychoactive substance use versus laboratory detection of substances by high-resolution mass spectrometry in patients presenting to an emergency department in London with acute drug toxicity.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1